Galecto (GLTO) Earnings Date & Reports

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GLTO is expected to report earnings to rise 18.81% to -23 cents per share on August 30

Q2'24

Est.

$-0.24

Q1'24

Est.

$-0.20

Q4'23

Est.

$-0.35

Q3'23

Beat

by $0.04

Q2'23

Beat

by $0.18

The last earnings report on April 26 showed earnings per share of -20 cents, missing the estimate of -20 cents. With 32.74K shares outstanding, the current market capitalization sits at 3.78M.

View a ticker or compare two or three

Compare

GLTO